Dietary intake of anthocyanins and risk of cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies

Research output: Contribution to journalReview article

Details

Original languageEnglish
Article number3032-3043
Pages (from-to)3032-3043
Number of pages12
JournalCritical Reviews in Food Science and Nutrition
Volume59
Issue number18
Early online date2 Oct 2018
DOIs
Publication statusPublished - 2 Jan 2020
Publication type

Research output: Contribution to journalReview article

Abstract

Accumulating evidence suggests flavonoid intake is associated with reduced risk of non-communicable diseases. We aimed to systematically determine and quantify the potential association between dietary anthocyanin intake and risk of cardiovascular diseases (CVD). A systematic literature search of studies reporting anthocyanin intake and risk of fatal or nonfatal CVD was performed using SCOPUS, MEDLINE, CINAHL and Cochrane Library. The relative risk (RR) or hazard ratio (HR) of highest category of anthocyanin foods were pooled in a random-effects meta-analysis. Subgroup analysis were conducted to determine possible sources of heterogeneity. The meta-analysis suggested intake of dietary anthocyanins and reduced risk of CHD (RR = 0.91, 95% CI: 0.83, 0.99; I 2 = 12.0, P h = 0.337) and CVD mortality (RR = 0.92, 95% CI: 0.87, 0.97; I 2 = 0.0, P h = 0.584). However, there was no relationship between the intake of these compounds and reduced risk of MI, stroke or total CVD. Subgroup analysis determined reduced risk of CHD and CVD mortality was more prominent for anthocyanidin intake, as opposed to anthocyanin or berries. Our systematic review and meta-analysis provides evidence that anthocyanins, specifically anthocyanidins, reduce the risk of CHD and CVD mortality. Further randomized controlled trials on anthocyanin intake and CVD risk factors are needed to support these findings.

Download Title (Resource: downloads_chaqrt)

No data available